FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump voices frustration with NATO, says Iranian navy ‘destroyed’ as US preps for blockade

Trump accuses Pope Leo of being ‘terrible’ on foreign policy over pontiff’s anti-war comments

Breaking: Eric Swalwell Suspends Campaign Amid Flurry of Sexual Assault Accusations

NYC mayor cites $180K racial wealth gap to justify taxes, police cuts

DOJ fires warning shot as Spanberger signs gun legislation

Iran, Uranium, and Epic Fury: All You Need To Know About The Iranian-U.S. Conflict

Blackmon: Drill, Baby, Drill Makes Modest Comeback

Op-Ed: The Economy Isn’t Perfect, But Crisis Talk Is Overstated and Politically Motivated

Atlanta teen arrested for murder after fatal shooting of 12-year-old inside home

Trump Judge Refuses to Block Sending Abortion Pills by Mail, But There’s Still Hope

Op-Ed: From Deplorable to Affordable – How the Dems Switched Out Lies for Campaign Messaging

Iran talks done in by Tehran’s delusions over leverage they don’t have, US official says

NBA Player Jaden Ivey Seen Street Preaching After Stand for Biblical Marriage

Victor Davis Hanson Breaks Down Why US Must Rethink NATO Strategy

Conservative group launches $5M ad blitz pressuring Senate on voter ID as GOP eyes SAVE America Act push

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”